Holding & Distribution
21 CFR Part 111 Subpart M (§§111.453–111.475) is the supplement-cGMP rule for holding (storing) components, packaging, labels, and finished dietary supplements — and for the distribution records that let the manufacturer trace, hold, or recall product from the field.
Read the full summary
It is the upstream and downstream bookends of the entire Part 111 framework, and the area that integrates most tightly with FSMA traceability and DSCSA-style chain-of-custody discipline.
On this page · 9 sections
- 1What Subpart M covers
- 2Holding conditions (§111.455)
- 3Mix-up prevention — the operational core
- 4In-process material (§111.460)
- 5Reserve sample storage (§111.465)
- 6Distribution and records (§§111.470, 111.475)
- 7Recall readiness — the test of the entire subpart
- 8Five 483 / Warning-Letter patterns
- 9How V5 Ultimate handles Subpart M
How does Holding & Distribution apply to your shop floor?
Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.
01What Subpart M covers
Subpart M brackets every other manufacturing activity. §111.453 requires written procedures for holding and distributing operations. §111.455 covers holding components, dietary supplements, packaging and labels under appropriate conditions. §111.460 applies to in-process material. §111.465 governs holding reserve samples. §111.470 requires distribution under conditions that protect against contamination and deterioration, and §111.475 requires records, including written procedures and records of product distribution, which support trace and recall.
02Holding conditions (§111.455)
§111.455 requires holding components and dietary supplements under appropriate conditions of temperature, humidity and light so identity, purity, strength and composition are not affected, and holding components, supplements, packaging and labels under conditions that do not lead to (1) contamination (cross-contamination from other materials, environmental contamination, pest contamination); (2) mix-up (one batch confused with another, one component confused with another); (3) deterioration (loss of identity, purity, strength, composition over the held period).
Operationally, this drives the following controls:
- Temperature and humidity control sufficient for the material — ambient (15–25°C, 30–70 % RH) for most supplements; cold-chain (2–8°C) for probiotics, enzymes, omega-3 in some formats.
- Continuous monitoring of temperature and humidity, with mapped warehouses and exception alerts.
- Light protection where required (vitamin A, D, folate, riboflavin) — opaque containers, lower-lux storage zones.
- Pest control program with monitoring stations, inspections, and corrective actions.
- Physical separation of components by status (quarantine, released, rejected) and by allergen class.
- Stack height and rack-load discipline to prevent crushing or container-closure failure.
03Mix-up prevention — the operational core
Mix-up prevention is the single most enforcement-active area within Subpart M. Practical controls:
- Unique location addressing (rack/level/position) with bar-coded location labels.
- Lot-controlled put-away — every receipt assigned to a specific location, scanned and confirmed.
- Status-segregated zones — Quarantine (yellow), Released (green), Rejected (red), Returns (orange).
- A defined stock-rotation method set out in written procedures (FEFO is a common choice, not a Part 111 requirement), picking only released, suitable stock.
- Two-person verification at any move between status zones (released → rejected, returns → reprocessing).
- Allergen segregation — known allergens (peanut, tree-nut, soy, dairy, egg, wheat, fish, shellfish, sesame) physically separated from non-allergen materials.
04In-process material (§111.460)
Material between manufacturing steps — blended bulk waiting for capsule filling, filled bottles waiting for capping, capped bottles waiting for labelling — must be held under the same standard as raw or finished material. The discipline:
- In-process containers identified with batch number, step completed, next step, status (in-process, on-hold, released-to-next-step).
- Hold time between steps documented; exceeding a defined hold time triggers a deviation investigation.
- Temperature and humidity control matched to the material's stability profile.
- Physical segregation from other batches and other products.
- Tamper-evidence (sealed containers, signed-off pallet wrap) for any hold longer than a shift.
05Reserve sample storage (§111.465)
Cross-referenced to §111.83 (which sets the collection and retention requirement), §111.465 requires the reserve sample to be held under conditions consistent with the product label or, if the label recommends no storage conditions, under ordinary storage conditions, in the same container-closure system as distributed. §111.465(b) requires retention for 1 year past the shelf-life date (if shelf-life dating is used), or for 2 years from the date of distribution of the last batch of dietary supplements associated with the reserve samples. Operational implications: a dedicated reserve-sample storage area, environmentally monitored, with restricted access (often QC-only key card), and with the chain-of-custody from receipt to disposal documented.
06Distribution and records (§§111.470, 111.475)
§111.453 requires written procedures for holding and distributing operations, and §111.475(b) requires those procedures and records of product distribution to be kept. Part 111 does not list the record fields; distribution records commonly capture:
- Name and address of the consignee.
- Date of shipment.
- Quantity, lot number, and identity of the dietary supplement shipped.
The distribution records are the foundation of any recall: they let the manufacturer identify, within hours, where every unit of a recalled lot went and reach the consignees. Records must be retained for 1 year past the shelf-life expiration date (or 2 years from distribution if no expiry). For supplements subject to FSMA Section 204 (rare for supplements but applicable when the supplement is also on the Food Traceability List), additional Key Data Element / Critical Tracking Event records apply.
07Recall readiness — the test of the entire subpart
The practical test of a Subpart M program is the recall mock exercise. A typical mock:
- Pick a random recent lot from the BPR system.
- Within 2 hours, identify every consignee that received units from that lot, with quantities and dates.
- Within 4 hours, identify the upstream component lots that went into that lot (via genealogy).
- Within 8 hours, identify other finished lots that used the same upstream component lots (lateral spread).
- Within 24 hours, produce the full FDA Form 3911-equivalent recall notification.
A program that cannot meet these timings is not recall-ready, and FDA's first action in a real recall investigation is to ask for the consignee list — failure to produce it promptly escalates the classification.
08Five 483 / Warning-Letter patterns
- No evidence that warehouse temperature/humidity are appropriate for the material — a §111.455 risk.
- Released and quarantined material commingled in the same rack location — a §111.455(c) mix-up risk.
- Holding and distributing operations not following the firm's own written procedures (§111.453) — e.g. stock rotation undefined, so product past its shelf-life date can be shipped.
- Distribution records limited to the customer's master record without per-shipment lot/date detail — a §111.475(b)(2) risk.
- Reserve samples held in the general warehouse without environmental control matching the product label — §111.465 finding.
09How V5 Ultimate handles Subpart M
- Locations table with location_type (quarantine | released | rejected | returns | reserve_sample | in_process), env_class (ambient | cold | controlled_room_temp), and barcode.
- Environmental monitoring ingestion — temperature/humidity sensors per zone; excursion alerts auto-open NCRs.
- FEFO is the default pick algorithm; FIFO/LIFO are opt-in per SKU.
- Allergen segregation rules: configurable allergen class flags on materials prevent commingling in the same rack.
- shipments table with consignee + date + lot + quantity; auto-populated from sales orders.
- Recall mode (/app/recalls/$id) generates consignee list + upstream component spread + lateral finished-lot impact in seconds.
- Reserve-sample storage location is environmentally monitored and QC-access-restricted.
Frequently asked questions
Q.What temperature is required for supplement storage?+
Part 111 does not prescribe a temperature — it requires conditions appropriate to prevent deterioration. For ambient supplements that is typically 15–25°C / 30–70 % RH; for cold-chain (probiotics, some enzymes, some oils) it is 2–8°C. The product's stability data is the source of truth.
Q.Is FEFO required by Part 111?+
No. Part 111 does not prescribe FEFO or any other picking method. §111.453 requires written procedures for holding and distributing operations, §111.455 and §111.470 require conditions that protect against contamination, mix-up and deterioration, and only released, suitable product should ship. FEFO is a common optional stock-rotation method; remaining shelf life relative to customer needs is a commercial and procedural choice the firm documents.
Q.Do I need to track temperature in real time, or are spot checks enough?+
Continuous monitoring is the industry norm and the FDA expectation for any material with a temperature-sensitive specification. Spot checks are accepted for clearly ambient-stable products in temperate warehouses, but real-time monitoring with excursion alerting is the safe default.
Q.What distribution records do I have to keep?+
§111.475(b)(2) requires records of product distribution; Part 111 does not list the fields, but consignee identity, shipment date, and the lot, quantity and identity shipped are commonly captured. Under §111.605, records are kept 1 year past the shelf life date (if shelf life dating is used) or 2 years beyond distribution of the last associated batch.
Q.Are wholesalers and distributors covered by Subpart M?+
The cGMP rule applies to the manufacturer. Wholesalers and distributors are covered by separate FDA expectations (cold-chain custody, holding integrity); the manufacturer's distribution record obligation ends at the first consignee but the chain-of-custody discipline is contractually pushed downstream.
Q.How fast must I be able to identify the consignees of a recalled lot?+
FDA expects within 24 hours during a recall. Industry best practice is within 2 hours — a target that requires the distribution records to be query-ready, not paper-stack.
Q.Does FSMA Section 204 apply to dietary supplements?+
Generally no — supplements are not on the Food Traceability List. But if a specific supplement contains an ingredient on the FTL (rare), Section 204 KDE/CTE records apply in addition to §111.475.
Primary sources
- 21 CFR 111.453 — Holding components, dietary supplements, packaging, and labels under appropriate conditions
- 21 CFR 111.455 — Holding components, dietary supplements, packaging and labels
- 21 CFR 111.460 — Holding in-process material
- 21 CFR 111.465 — Holding reserve samples of dietary supplements
- 21 CFR 111.470 — Distributing dietary supplements
- 21 CFR 111.475 — Subpart M records
- FSMA Section 204 — Enhanced Recordkeeping Requirements for High-Risk Foods (21 CFR Part 1 Subpart S)
Further reading
- 21 CFR Part 111The full supplement cGMP framework.
- Reserve sample (111.83)What 111.465 holds and for how long.
- Supplement Stability & Shelf LifeWhy temperature/humidity control during holding matters.
- FEFOFirst-Expire-First-Out picking discipline at distribution.
- Cold Chain ValidationWhen the held material requires refrigerated conditions.
Want to see how Holding & Distribution could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.